imatinib mesylate has been researched along with Bile Duct Obstruction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, H; Horike, SI; Kato, Y; Kawanishi, T; Meguro-Horike, M; Nishiuchi, T; Shengyu, D; Sugimoto, M | 1 |
| Arakawa, H; Kato, Y; Kawanishi, T; Masuo, Y; Nakamichi, N | 1 |
| Gendron, MC; Goria, O; Housset, C; Kinnman, N; Poupon, R; Rey, C; Wendum, D | 1 |
3 other study(ies) available for imatinib mesylate and Bile Duct Obstruction
| Article | Year |
|---|---|
Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice.
Topics: Animals; Bile Ducts; Cholestasis; Cisplatin; Down-Regulation; Imatinib Mesylate; Kidney; Liver; Liver Diseases; Membrane Transport Proteins; Mice; Multidrug Resistance-Associated Proteins; Proteomics | 2023 |
Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib.
Topics: Administration, Intravenous; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Membrane; Cholestasis; Disease Models, Animal; Humans; Imatinib Mesylate; Intestinal Absorption; Intestinal Mucosa; Male; Mice; Microvilli; Up-Regulation | 2019 |
Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.
Topics: Actins; Animals; Benzamides; Bromodeoxyuridine; Cell Division; Cholestasis; Enzyme Inhibitors; Imatinib Mesylate; Liver; Male; Muscle, Smooth; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Time Factors; Up-Regulation | 2001 |